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Background/aim: Idiopathic granulomatous mastitis (IGM) is a rare, chronic inflammatory disease of the breast. Erythema nodosum
(EN) is a rare extramammary manifestation of IGM. The purpose of this study is to determine the clinical and demographic characteristics
of 11 IGM and EN patients and to evaluate the efficacy of methylprednisolone treatment.
Materials and methods: In our series, ten patients had EN bilaterally, whereas one patient had a lesion of the right pretibial area. The
mean age of the patients was 35.5 years (range: 29–45 years). IGM and EN were diagnosed by the necessary serological, microbiological,
radiological, and histopathological examination. After diagnosis, methylprednisolone was started in the first week at 0.8 mg/kg daily for
treatment. The weekly dose was tapered to 0.1 mg/kg daily over 8 weeks.
Results: We started with the treatment of methylprednisolone, and in all our cases the initial response was excellent. In 2 weeks the IGM
symptoms had markedly declined, while signs of EN disappeared completely. Patients were followed for an average of 60 months after
treatment. None of the 11 patients had recurrence.
Conclusion: We herein report a rare series considering IGM cases complicated by EN. Few such cases have been reported in the
literature. We advocate for an initial trial of methylprednisolone treatment, which proved to be very successful in our patients.
Key words: Granulomatous mastitis, idiopathic granulomatous mastitis, erythema nodosum, breast, corticosteroids

1. Introduction
Granulomatous lobular mastitis (GLM) is a rare
inflammatory breast disease (1). It usually presents with
an irregular circumscribed breast mass, breast pain, nipple
inversion, cutaneous ulceration, induration, erythema, and
cutaneous fistula formation. Its radiological and clinical
symptoms are similar to breast carcinoma, so unnecessary
surgical procedures are likely to be applied. There are
two forms of GLM: idiopathic granulomatous mastitis
(IGM) and specific granulomatous mastitis. Parasitic
infections with specific effects, tuberculosis, Wegener
granulomatosis, sarcoidosis, histoplasmosis, foreign
bodies, and fungi should be excluded in potential cases of
IGM (2). Erythema nodosum (EN) is the most common
type of panniculitis and is characterized by reddish,
painful nodules in the subcutaneous area. It is typically
located in pretibial regions bilaterally (3). EN is a rare
systemic manifestation of IGM. The relationship between
* Correspondence: makin@gazi.edu.tr
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IGM and EN was first described by Adams in 1987 (4).
The purpose of this study is to determine the clinical and
demographic characteristics of 11 IGM and EN patients
and to evaluate the efficacy of methylprednisolone over a
long follow-up period.
2. Materials and methods
Eleven patients who were admitted to the General
Surgery Outpatient Clinic of the Gazi University Faculty
of Medicine between 2006 and 2015 with complaints of
breast mass and cutaneous fistula formation, who were
diagnosed with IGM (Figure 1A) with concurrent varying
numbers of pretibial subcutaneous nodular lesions
consistent with EN (Figure 1B), were selected. Abscess
and tissue cultures were obtained from the patients for
microbiological examination. Antibiotic therapy was
planned according to these results. Acid-resident bacteria,
Löwenstein–Jensen culture, and tissue polymerase

AKIN et al. / Turk J Med Sci

Figure 1A. Granulomatous lobular mastitis on the left breast.
Figure 1B. Erythema nodosum on the left tibia.
Figure 1C. Granulomatous lobular mastitis with characteristic ductolobulocentric pattern (H&E, 200×).
Figure 1D. Erythema nodosum characterized by septal panniculitis in the subcutaneous adipose tissue (H&E, 20×).

chain reaction (PCR) were evaluated when needed for
tuberculosis research. Hematoxylin and eosin (H&E)
staining for histopathological examination, Gram staining
for the detection of microorganisms, Ziehl–Neelsen (ZN)
staining for tuberculosis, and periodic acid–Schiff (PAS)
staining for fungal infection were applied to all pathological
preparations. Serum angiotensin-converting enzyme
levels and serum calcium were normal. After radiological
examination for breast lesions and dermatological
examination for skin lesions, a histopathological
examination was done in order to confirm the clinical
diagnosis for both lesions (histopathological examination
was performed for 4 patients for EN diagnosis). Patients’
laboratory results revealed leukocyte counts of >10,000/
mm3 with an elevated erythrocyte sedimentation rate and
C-reactive protein titer. Ten patients had EN bilaterally,
whereas one patient had a lesion of the right pretibial area.
The mean age of the patients was 35.5 years (range: 29–45

years). Four patients had no history of marriage and no
reported children. There was history of at least one live
birth in the 7 (63.63%) remaining patients. The number
of patients with lactation history in the last 12 months
was 6 (54.54%), while the number of patients using oral
contraceptives was 4 (36.36%). Four patients (36.36%)
were smokers. Methylprednisolone was started in the first
week at 0.8 mg/kg daily for treatment. The weekly dose
was tapered to 0.1 mg/kg daily over 8 weeks.
3. Results
In our series, IGM symptoms and signs had declined
and EN lesions had completely disappeared 2 weeks after
the start of treatment. Complete recovery of symptoms
and signs of IGM occurred after 12 weeks. Patients were
followed for an average of 60 (16–110) months after
treatment. None of the 11 patients had recurrence or side
effects.
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4. Discussion
Specific diagnosis of GLM was described for the first time
by Kessler and Walloch in 1972 (5). Patients present with a
breast mass, nonhealing abscesses, and cutaneous fistulae.
In the literature, lesions have been reported to usually
affect a single breast, and involvement of the periareolar
region has been rarely reported. Redness, thickening
of the breast skin, and a palpable hard mass may also be
present, as well as some foci of fistula openings in the
lesion area (6,7). Our patients also had this type of breast
lesion. Diagnosis was confirmed pathologically upon a
suspicious mass being detected by radiological evaluation.
Histopathologically, noncaseous granulomatous structures
consisting mainly of epithelioid histiocytes, lymphocytes,
and several Langhans-type giant cells that destruct terminal
ductolobular units of the breast with ductolobulocentric
patterns can usually be noticed (Figure 1C). On the
other hand, histopathologically, EN is characterized by
septal panniculitis in the subcutaneous adipose tissue
(Figure 1D). Other entities of granulomatous mastitis
(tuberculosis, sarcoidosis, fungal infection, etc.) must be
studiously excluded. In 1987, Adams et al. described the
first case of concurrent IGM and EN (4). Only a few reports
are available in the literature presenting several cases

(8). Polyarthritis and EN are rare, but they are the most
frequent systemic manifestations of IGM. Although cases
of IGM complicated solely by EN are very rarely reported,
to our knowledge, only ten other cases of IGM complicated
by both arthritis and EN have been previously reported. All
the patients received immunosuppressive treatment (9,10).
It should be considered that IGM and EN may have similar
autoimmune mechanisms during their development.
There is still no consensus for IGM treatment in the
literature. Corticosteroid therapy was first proposed in
1980 by DeHertog et al. There are studies that advocate
the use of steroid treatment at high doses in primary cases,
and those advocating that steroid treatment is effective in
resistant cases (11). We, as well, started treatment with
methylprednisolone, and in all of our cases the initial
response to prednisolone was excellent: in 2 weeks the
IGM symptoms had markedly declined, while signs of EN
had disappeared completely. In our series, patients were
followed for an average of 60 months after treatment.
None of the 11 patients had recurrence.
In conclusion, we herein report a rare series considering
IGM cases complicated by EN. We advocate for an initial
trial of methylprednisolone treatment that proved to be
very successful in our patients.
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